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Abstract
Background:  Substantial reductions in maternal mortality are called for in Millennium
Development Goal 5 (MDG-5), thus assuming that maternal mortality is measurable. A key
difficulty is attributing causes of death for the many women who die unaided in developing
countries. Verbal autopsy (VA) can elicit circumstances of death, but data need to be interpreted
reliably and consistently to serve as global indicators. Recent developments in probabilistic
modelling of VA interpretation are adapted and assessed here for the specific circumstances of
pregnancy-related death.
Methods: A preliminary version of the InterVA-M probabilistic VA interpretation model was
developed and refined with adult female VA data from several sources, and then assessed against
258 additional VA interviews from Burkina Faso. Likely causes of death produced by the model
were compared with causes previously determined by local physicians. Distinction was made
between free-text and closed-question data in the VA interviews, to assess the added value of free-
text material on the model's output.
Results: Following rationalisation between the model and physician interpretations, cause-specific
mortality fractions were broadly similar. Case-by-case agreement between the model and any of
the reviewing physicians reached approximately 60%, rising to approximately 80% when cases with
a discrepancy were reviewed by an additional physician. Cardiovascular disease and malaria showed
the largest differences between the methods, and the attribution of infections related to pregnancy
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also varied. The model estimated 30% of deaths to be pregnancy-related, of which half were due
to direct causes. Data derived from free-text made no appreciable difference.
Conclusion:  InterVA-M represents a potentially valuable new tool for measuring maternal
mortality in an efficient, consistent and standardised way. Further development, refinement and
validation are planned. It could become a routine tool in research and service settings where levels
and changes in pregnancy-related deaths need to be measured, for example in assessing progress
towards MDG-5.
Background
The Fifth Millennium Development Goal (MDG-5) calls
for a 75% reduction in maternal mortality by 2015. Meas-
uring this target with sufficient precision to show such a
downward trend is, however, a major challenge, particu-
larly in high mortality settings with weak health informa-
tion systems[1,2]. Deaths for more than 50% of the
world's population go unrecorded in official statistics,
including the majority of pregnancy-related deaths[3].
Thus developing practical methods which can consist-
ently and reliably help identify otherwise missed preg-
nancy-related deaths in the community is an urgent
priority in order to show and inform progress towards
MDG-5.
Verbal autopsy (VA) is an established method of ascer-
taining likely causes of death in settings where death reg-
istration is non-existent or inadequate. Relatives or
caretakers of the deceased are interviewed to elicit the cir-
cumstances and symptoms of the death. These data are
then interpreted to derive likely causes of death; however,
it is at this stage that the limitations of VA become most
apparent. Commonly, local physicians assign individual
causes of death based on information from the VA inter-
view. This takes time and consumes valuable skilled
resources, often in settings where physicians are scarce.
Moreover, the reliability and repeatability of interpreta-
tion by physicians has been questioned [4-9]. In Bangla-
desh, for example, one physician attributed 41% of all
maternal deaths to direct obstetric causes, while another
group determined the proportion as 51%[5]. Such dis-
crepancies can be misleading and preclude comparisons
of cause-specific mortality determined by physician
review between regions and over time, where different
physicians and their methods of interpreting evidence
may differ. How to accurately interpret VA interview mate-
rial, especially for a large number of cases, thus remains a
major methodological obstacle. Approaches such as algo-
rithms and neural networks have been tried inconclu-
sively in some settings, and have often been criticised for
excluding multiple causes of death[4,7].
Monitoring progress towards MDG-5 requires popula-
tion-based identification of deaths among women of
reproductive age (occurring in health facilities, at home,
or elsewhere), followed by determination of cause in
order to identify maternal deaths[10]. Methodological
limitations in interpreting VA data are therefore a signifi-
cant barrier to accurately measuring the burden and
causes of pregnancy-related death and preclude rigorous
evaluations of the effectiveness of safe-motherhood inter-
vention strategies. In order to tackle the problem of mater-
nal mortality, and move closer to achieving MDG-5, new
approaches to measuring cause-specific mortality among
women of reproductive age need to be developed, vali-
dated and discussed.
The InterVA model[11]
Recent development of a probabilistic approach to VA
interpretation designed to overcome the weaknesses of
physician reviews and algorithms has delivered promising
results [12-14]. Based on Bayes' theorem, this novel
approach processes indicators from VA data rapidly and
lists up to three likely causes of death for each case. A like-
lihood for each cause of death and an overall certainty fac-
tor is reported. Validation of the InterVA model in
Vietnam and Ethiopia, settings with markedly different
mortality patterns, correlated well with local physician
reviews, and the one model was able to reflect local varia-
tions in mortality. Detailed descriptions of the develop-
ment of the probabilistic model and its validation are
available elsewhere [12-14].
This paper describes the adaptation of the general InterVA
model into a specialised maternal version, InterVA-M, for
interpreting VA data for deaths of women of reproductive
age (15–49 years), and compares findings with previous
physician reviews. A more complex and specialised model
was necessary for pregnancy-related deaths, to include
assessment of a particular death being pregnancy-related,
as well as more detailed pregnancy-related causes of death
and corresponding indicators.
Methods
Based on previous work, a list of signs, symptoms and
causes of death for women of reproductive age was agreed
upon by an experienced international physician panel,
familiar with clinical practice in developing countries and
the process of VA. Probabilities reflecting the occurrence
of each cause and each indicator among female deaths inPopulation Health Metrics 2007, 5:1 http://www.pophealthmetrics.com/content/5/1/1
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the 15–49 year age range, and for each indicator given a
specific cause, were determined by the panel using a Del-
phi technique. The InterVA-M model then uses a Bayesian
approach to process these probabilities, implemented
using Microsoft Visual FoxPro. As with the all-cause
InterVA program, InterVA-M presents up to 3 causes of
death, each with a percentage likelihood, and an overall
certainty factor, defined as the average of the likelihoods.
Cases with more detailed VA data usually result in higher
likelihoods and hence a higher overall certainty. In addi-
tion, the maternal model attributes a likelihood for each
case being pregnant at death, dying within 6 weeks of
pregnancy ending, or not being recently pregnant.
The InterVA-M model was tested and assessed in collabo-
ration with the Centre de Recherche en Santé de Nouna
(CRSN), a demographic surveillance site (DSS) situated in
rural north-west Burkina Faso. CRSN has undertaken VA
Table 1: Indicators and causes of death used in the InterVA-M model
Indicators Causes
was she pregnant at death had professional assistance at delivery HIV/AIDS related death
died within 6 w of delivering a baby was delivery by Caesarean malaria
died within 6 w of early pregnancy ending was delivery by forceps/Ventouse tuberculosis (pulmonary)
said to be non-pregnant 6 wks before death did uterus came out after delivery hepatitis
was she married at time of death any swelling of feet and ankles cardiovascular disease
was death during wet season any swelling of face respiratory disease
was she aged under 20 yrs any blurred vision injury
was she aged 20 to 34 yrs any acute abdominal pain suicide
was she aged 35 to 49 yrs any foul smelling vaginal discharge cancer
had she ever been pregnant any previous Caesarian section ---------------------------------------
was she breast-feeding before death any stiff neck not pregnant within 6 weeks of death
was the pregnancy unwanted any excessive night sweats pregnancy ended within 6 weeks of death
any attempt to terminate pregnancy any enlarged swollen glands pregnant at death
was this her first pregnancy any persistent cough > 3 wks ---------------------------------------
were there >4 previous pregnancies any persistent fever > 3 wks haemorrhage
was this a multiple pregnancy was she coughing up blood pregnancy-related sepsis
was she < 3 months pregnant at death any jaundice or yellowness of skin/eyes non-pregnancy related infection
any history of acute fever any ulceration or infected wound obstructed labour
any required IV or IM antibiotics was she immunized against tetanus ruptured uterus
was there coma >24 hrs before death did she require iron injections pregnancy-induced hypertension
did she ever have fits any diagnosis of epilepsy abortion
any pallor and/or anaemia any diagnosis of TB anaemia
any general swelling of body any diagnosis of HIV/AIDS ectopic pregnancy
breathless carrying out normal activities any diagnosis of thrush
any weight loss any diagnosis of Karposi's sarcoma
Recently bed bound for most of day any diagnosis of malaria
any sudden collapse any diagnosis of liver disease
any blood transfusion required any diagnosis of haemoglobinopathy
hysterectomy shortly before death any surgery in month before death
any recurrent fever any diagnosis of cancer
any shivering with fever any diagnosis of heart disease
major bleeding in 1st 3 months of preg any suggestion of recent injury
major bleeding in pregnancy or delivery any suggestion of suicide
did the placenta remain inside
was death within 24 hrs of preg ending
any delay in reduction of uterus size
was blood pressure raised during preg
any proteinuria reported
were fits only pregnancy related
was labour prolonged >24 hr
was a baby delivered alive
did she die in labour undelivered
was baby's position abnormal
was baby too big for delivery
was part of baby prolapsed
was delivery at home
was delivery at a health facilityPopulation Health Metrics 2007, 5:1 http://www.pophealthmetrics.com/content/5/1/1
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routinely over a long period, in an area typical of the high
maternal mortality ratio found in Burkina Faso (1,000/
100,000 live births) [15-17].
Since 1992, CRSN fieldworkers have followed up every
death, after a culturally appropriate period of three
months' mourning, by interviewing a friend or family
member using a VA questionnaire which has evolved in
close collaboration with WHO and INDEPTH [18] and
been adapted for the local setting. Wherever possible, the
primary caretaker of the deceased immediately before
death was interviewed and information relating to the
signs, symptoms and circumstances of death collected.
The questionnaire consisted of open-ended as well as
fixed-response questions.
Completed VA forms for all deaths in the Nouna DSS
since 1992 were scrutinised and those pertaining to
females aged 15–49 years extracted and recorded in a
spreadsheet format. This yielded data on 380 deaths, each
of which had been assessed by local physicians. Approxi-
mately one third of these cases (n = 122) were used for ini-
tial testing of the probabilistic model to highlight any
errors or omissions, which were then presented to and dis-
cussed by the expert panel. In addition to the 122 cases
from CRSN, archived VA data for 203 obstetric-related
deaths from Bangladesh, 18 adult female deaths from
Ethiopia and 15 adult female deaths from Ghana were
also used in this initial testing to avoid modelling the
Burkina Faso setting too specifically. From this process, a
definitive list of 80 indicators and 21 causes was formu-
Representation of the burden of each of the major cause of death categories derived by local physician review and InterVA-M  interpretation of VA data for 258 adult female deaths in Nouna, Burkina Faso Figure 1
Representation of the burden of each of the major cause of death categories derived by local physician review and InterVA-M 
interpretation of VA data for 258 adult female deaths in Nouna, Burkina Faso. The two central columns represent groups of 
causes to facilitate comparison.
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lated as the basis of the model for further assessment, as
shown in Table 1.
This probabilistic model was then assessed using the hith-
erto untouched 258 cases of adult female death from
CRSN, by comparing the results from the probabilistic
model with the original physician reviews. Following
CRSN's usual procedures, initially two specially trained
local physicians had reviewed each case, trying to reach
consensus on a single cause of death based on adapted
ICD-10 categories. Where no consensus was reached, a
third physician, not blinded to the opinions of the other
physicians, reviewed the data in order to arrive at a con-
sensus cause of death.
Consensus was reached on a single cause of death by the
two reviewing physicians in only 102/258 (39.5%) cases.
The remaining 156 cases (60.5%) were reviewed by the
third independent physician, after which a two-thirds
majority consensus on a single cause of death was reached
in a total of 240 cases (93%), although in 30 of these the
result was "indeterminate". No consensus was reached in
18 cases (7%).
Given the diversity of the original physician opinions, for
the purposes of this assessment each individual physician
diagnosis was used, weighted according to the number of
physicians reviewing the case. This allowed comparison
with the InterVA-M model's possible multiple causes,
which were weighted by their likelihoods. Thus the same
original VA questionnaire data were processed independ-
ently by the original physicians and the model, giving
individually assigned cause(s) of death by both methods.
These were then aggregated to cause specific mortality
fractions (CSMF) at the community level.
Emphasis is often placed on the importance of open-
ended, free-text information collected using VA question-
naires[19,20]. This frequently includes verbatim accounts
from respondents, which probably fit better with physi-
cians' customary approaches to diagnosis than a series of
closed questions. The omission of open-ended informa-
tion from most algorithmic approaches to VA interpreta-
tion has been a major criticism. Thus indicators which
were extracted solely from the free-text sections of the
CRSN VA forms were distinguished, to assess the added
value of the free-text information. All the cases were proc-
essed with and without including the exclusively free-text
indicators.
This study received ethical approval from the Centre
Muraz Ethical Clearance Committee, Burkina Faso and
from the Institutional Review Board of CRSN. In addition,
informed consent was obtained from participants before
VA interviews were conducted.
Results
Examination of the range of causes assigned by physicians
and InterVA-M revealed some important differences in
terminology and cause of death categories. In many cases
the physicians tended towards specific descriptions, for
example "cardiopathy", in preference to more general
cause of death categories, such as "cardiovascular disease".
The following comparison is based on a rationalisation
between the physician-assigned causes and the possible
causes in the InterVA-M program. Figure 1 shows this,
whilst also indicating the overall burden of each cause of
death category in Nouna according to the two VA interpre-
tation methods.
It was decided to group HIV/AIDS related deaths and
deaths due to pulmonary tuberculosis (TB) into a single
category for the assessment in this study since there was a
large overlap of cases identified as being HIV/AIDS related
by physician review and cases identified as being due to
TB by the probabilistic model. Grouping HIV/AIDS and
TB is reasonable given the significant clinical overlap
between the two conditions and that around one quarter
of those living with HIV are coinfected with TB[21].
Table 2 describes the case-by-case correlations between
InterVA-M and physician reviews. In 123 cases (47.7%)
the most likely cause as determined by the probabilistic
model corresponds with at least one of the reviewing phy-
sicians. In an additional 25 cases (9.9%), at least one of
the three most likely causes determined by the probabilis-
tic model corresponds with at least one of the causes given
by the physicians. In 110 cases (42.6%), the model's out-
put contradicted the opinions of the reviewing physicians.
However, in a number of cases, it was not clear that the
physicians' diagnoses were more consistent with the VA
data than those of the model. Therefore data from the 110
Table 2: Summary of case-by-case agreement between InterVA-M and physician review.
correspondence of most likely cause correspondence of any cause
original physician review 123 (47.7%) 148 (57.4%)
indicators from free-text removed 124 (48.1%) 147 (57.0%)
"malaria diagnosis" indicator removed 132 (51.2%) 154 (59.7%)
following physician reassessment 179 (69.4%) 211 (81.8%)Population Health Metrics 2007, 5:1 http://www.pophealthmetrics.com/content/5/1/1
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non-matching cases were presented to an additional,
independent obstetrician, familiar with VA and obstetric
practice in sub-Saharan Africa, who had not been
involved in the development of InterVA-M (UH). This
reassessment gave causes agreeing with the model in 63/
110 cases (57.3%) (56 of which agreed with the model's
most likely cause); causes which were in accordance with
at least one of the original reviewing physicians in 18
cases (16.4%), and completely different causes for 29
cases (26.4%). Thus the model can be considered to have
reached similar conclusions to a combination of the orig-
inal physician reviews plus the physician reassessment in
211 (81.8%) of the overall cases. The CSMFs according to
InterVA-M, original physician review and after reassess-
ment are shown in Figure 2.
The model overestimated pregnancy-related sepsis com-
pared with physician reviews, and underestimated other,
non-pregnancy related infections and HIV-related deaths.
Most contradictory cases identified as pregnancy-related
sepsis by the model corresponded with physician diag-
noses of non-pregnancy related infection and HIV-related
death. However, since relatively few adult women die
from infections in general, and in Burkina Faso approxi-
mately one third of deaths of females of reproductive age
occur in pregnancy or within 6 weeks of pregnancy end-
ing[22], then the prevalence of pregnancy-related sepsis
compared with non-pregnancy related infections as deter-
mined by InterVA-M may be reasonable. The fact that
pregnancy-specific indicators were included in almost half
of these mismatched cases raises questions as to how the
reviewing physicians originally interpreted this informa-
tion.
The CSMF for cardiovascular diseases (CVD) varied
between the two methods of interpretation, with physi-
cians identifying more than six times the number of CVD
deaths than the model. One third of the mismatched CVD
cases, which included physician diagnoses of cardiopathy,
hypertension, stroke and "maux de coeur", corresponded
to diagnoses of indeterminate cause by the model and
most lacked any obvious CVD signs or symptoms, thus
raising the question whether these diagnoses were simply
describing the inevitable heart failure ultimately associ-
ated with death. The fact that physician reassessment
identified the majority of these cases as indeterminate
supports this, and suggests this may be a more appropriate
public health outcome.
Malaria as a cause of death posed further diagnostic diffi-
culties. Pregnant women are known to be at greater risk
from malaria, yet malaria in pregnancy is frequently
under-estimated, both clinically and in public health.
Even in areas of relatively low transmission, many preg-
nant women may be infected at least once[23]. In Nouna,
malaria is holoendemic, so most women will have been
exposed to malaria before pregnancy and will have
acquired some immunity. Nevertheless, semi-immune
women are more susceptible during pregnancy with a
clinical picture ranging from asymptomatic infection to
severe, life-threatening illness[23,24].
Previous work on mortality in Nouna explained that
malaria was not easily distinguished from other febrile ill-
nesses using VA and the authors decided to group these
causes together for the purposes of analysis[17]. Local
physicians' tendency to diagnose other infections and
febrile illnesses rather than malaria may be reflected in
their diagnosis of approximately 30% of the mismatched
malaria cases as non-pregnancy related infections, and a
further 30% as HIV-related deaths. Since HIV-infected
pregnant women are more likely to develop clinical
malaria, it seems that there may be some overlap between
these diagnoses that requires further consideration in
refining the probabilistic model.
A further difference in malaria rates between the two
methods was due to a history of malaria treatment in the
VA interview being taken in the model as a "diagnosis of
malaria". Although malaria treatment was commonly
reported, it did not seem to greatly influence the reviewing
physicians as to the cause of death, possibly reflecting
their local knowledge of over-prescribing of antimalarials.
To test this hypothesis, the model was re-run with all
"diagnosis of malaria" indicators removed. This made the
malaria CSMF for the two approaches more comparable
(Figure 2), although the case-by-case agreement between
InterVA-M and physician review was not significantly
altered (Table 2).
Cause-specific mortality fractions (CSMF) for 258 female  deaths (15–49 years) from Burkina Faso according to differ- ent interpretations of verbal autopsy data Figure 2
Cause-specific mortality fractions (CSMF) for 258 female 
deaths (15–49 years) from Burkina Faso according to differ-
ent interpretations of verbal autopsy data.
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The model assessed 21 women (8.1%) to have been preg-
nant at death (mean of individual likelihood values for
pregnant at death = 79.4%), 56 (21.7%) to have died
within 6 weeks of pregnancy ending (mean of individual
likelihood values for death within 6 weeks of pregnancy
ending = 85.4%), and 181 (70.2%) not to have been preg-
nant within 6 weeks of death (mean of individual likeli-
hood values for not pregnant within 6 weeks of death =
87.8%). Thus pregnancy-related deaths amounted to
29.8% of mortality among women of reproductive age, of
which half (15.1%) were attributed to direct maternal
causes.
The effect of including or excluding exclusively free-text
indicators in the input to the InterVA-M model made no
significant difference to the results. Differences in agree-
ment with physician opinions and in the magnitude of
CSMFs were in all cases less than 1%.
Discussion
Adapting the all-cause model for interpreting VA material
from reproductive age female deaths gave CSMFs that
were broadly comparable to physician reviews, in the
absence of any available "gold standard", while also offer-
ing inherent consistency of interpretation over time and
place. Reliable and consistent estimates of CSMFs, includ-
ing attribution of mortality to pregnancy-related causes, at
the population level, are the key requirements for moni-
toring MDG-5. Whilst statistical modelling may not reflect
all the subjective subtleties that reviewing physicians
might apply to individual cases, it offers very significant
advantages in terms of efficiency, consistency and stand-
ardisation.
Rigorous validation of VA procedures is needed to estab-
lish confidence in the data collected, in order to under-
stand the operational characteristics of VA in the
populations under study and to identify misclassification
patterns, which may then be corrected[25,26]. Poor valid-
ity for specific causes or cause-of-death categories raises
questions not only about the utility of the specific VA tool,
but also about the questionnaire used to collect data,
interviewer skills and household awareness of health and
disease. The extent of differences within the original phy-
sician diagnoses and the differences revealed in subse-
quent physician reassessment in the current study
highlight the lack of standardisation inherent in physician
interpretation of VA material. It was not possible, with
these data, to robustly validate the model by comparison
with original physician assessments. We accept that the
process of reassessment by a further physician, as
described above, may do more to illustrate the vagaries of
VA interpretation than to provide a standard for valida-
tion, but it is important to recognise that in many settings
there is no absolute "gold standard" by which to validate
the performance of alternative VA interpretative models.
What is often termed "validation of VA" includes multiple
components (validity and standardisation of VA instru-
ments and interview, validity of VA interpretation(s),
validity of arbitration between various interpreters and
multiple validity issues around candidate "gold stand-
ards" such as medical record assessments). Discussions of
VA validity typically focus on sensitivity, specificity and
positive predictive values (PPVs) derived by comparing
VA diagnoses with a reference diagnosis. In general, two
types of reference "gold-standards" are used for validating
VA tools: health-facility-based diagnoses or diagnoses
derived from medical records, and community-based
physician review diagnoses[7,19,27]. Whilst facility-based
validations enable comparison of VA findings with a com-
paratively highly accurate medical diagnosis of cause of
death, such studies are subject to selection and informa-
tion bias and do not represent the populations for whom
VA is intended, most of whom die without medical atten-
tion. Deaths from haemorrhage, for example, occur more
rapidly than deaths from obstructed labour or pregnancy-
related sepsis, and therefore they are likely to be under-
represented in facility-based validations since haemor-
rhaging individuals will be less likely to reach a hospital
before death; this is particularly true in areas with poor
transportation.
Ideally therefore, the validity of VA should be assessed
using a sample of community-based deaths. Physician
review of VA data from community-based deaths has spe-
cific limitations, which have already been highlighted
here and by others[9,19]. Issues of sampling communities
for VA validation studies and the difficulty of tracing med-
ical records (if they exist) to support physician diagnoses
are further limitations of community-based studies.
Discussions of validity in terms of sensitivity, specificity
and PPV assume that the referent diagnosis gives the right
answer. This is reasonable if the objective is to assess
whether alternate interpretation methods can be as accu-
rate as the reference standards in the specific setting and
time period of interest. It has been acknowledged, how-
ever, that VA diagnoses may be more accurate than the ref-
erent diagnosis in some instances[4,7,28]. Though not a
formal validation of InterVA-M against the usual gold
standards employed in VA studies, the current study com-
pares the results from the probabilistic model with physi-
cian review of the data, and assesses the model's
performance in terms of comparability, reliability and
adequacy of purpose, avoiding reference to sensitivity,
specificity or PPVs, which would imply inherent superior-
ity of the physician review method. Efforts have been
made to adjust imperfect gold standards, including adjust-Population Health Metrics 2007, 5:1 http://www.pophealthmetrics.com/content/5/1/1
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ing for the quality and quantity of evidence in support of
the reference standard[8,28] and such techniques may
provide an opportunity for more thorough demonstra-
tions of validity of InterVA-M against proxy gold-stand-
ards, at least for certain causes of death, in the future.
The proportion of deaths identified by the probabilistic
model as being during pregnancy or within 6 weeks of
pregnancy ending (30%) was slightly lower than the pro-
portion of maternal deaths among deaths of all females of
reproductive age for Burkina Faso as estimated by WHO,
UNICEF and UNFPA (37%)[22]. However, this discrep-
ancy is not simple to account for in the light of the mod-
elling used to arrive at national estimates and the
possibility of local differences in mortality patterns.
Categorisation of pregnancy-related deaths as direct or
indirect, or pre-, inter- or post-partum, will never be easy
using VA data. The current version of the model does not
attempt an "intra-partum" category, although the combi-
nation of the pregnant/recently delivered categorisation
with specific maternal causes can reveal this to some
extent. In principle the model could be adapted further
around these issues, but more work is needed on arriving
at consensus requirements.
The omission of free-text information from various algo-
rithmic approaches to VA interpretation has hindered
their acceptance and caused concern over validity[19,20].
One study showed that the sensitivity of VA using physi-
cian review for neonatal causes of death was lower when
only closed questions were used[29]. Whilst InterVA-M
can be used with any kind of VA data, the process of iden-
tifying and extracting indicators from open-text often
requires greater medical knowledge and subjectivity. Nev-
ertheless, this study suggests little or no benefit from this
process, in concordance with an earlier study[30]. It may
be the case that free-text information is more informative
to physician reviewers than to modelling processes[31],
but frequently much information is duplicated between
open and closed sections of VA interviews, possibly pro-
longing the process unnecessarily. Further investigation
into the value of free-text information for the InterVA
method is anticipated using existing VA data.
The possible precision of VA methods continues to be
debated. For public health monitoring, the greatest preci-
sion is needed to distinguish between causes that might be
the targets of viable interventions. Generating possible
multiple causes of death is likely to more accurately reflect
the interactions between different diseases that lead to
death and more realistically highlight the dominant mor-
bidity and mortality burdens at the community level.
Insisting on single causes of death could distort estimates
of overall mortality and potential gains from health inter-
ventions[19]. Weighting single deaths among several
causes could complicate analysis and comparison with
other studies[20,32]. However, previous work with
InterVA data has incorporated this approach success-
fully[12,13]. InterVA-M may also be well suited to public
health monitoring using the established standards of the
international death certificate (ICD-10), which allows for
multiple causes in a causal pathway leading to death,
however further consideration of interpreting the
sequencing of events in InterVA-M is needed.
The InterVA-M model will now move on to being
reviewed by a further expert panel, drawn from a range of
diverse settings, to review the indicators, possible causes
and associated probabilities currently used in the model,
together with conceptual and contextual issues regarding
terminology and regional variation. A similar process for
the all-cause model resulted in an improvement in its
overall performance[13]. To ensure that InterVA-M
becomes an acceptable tool for use across the developing
world, both in research and service settings, we hope to
find opportunities for more robust validation studies. A
pilot version of the InterVA-M model implemented on a
handheld computer (PDA) which allows direct capture
and interpretation of VA data is also under test. Mean-
while, the preliminary version of the model, as described
here, can be downloaded from the InterVA website[11].
Conclusion
InterVA-M represents a potentially valuable new tool for
objectively measuring maternal mortality and addressing
some of the weaknesses of VA methodologies. With fur-
ther refinement and validation it could become a routine
tool for use both in research and service settings where
levels and changes in pregnancy-related deaths need to be
measured, for example in assessing progress towards
MDG-5.
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